Petros Pharmaceuticals, Inc.
PTPI
Rank in Stocks
#33850
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male... Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Share Price
$0.003
Last synced: 2026-11-13
Market Cap
$142.18K
Change (1 day)
6.57%
Change (1 year)
-82.35%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Petros Pharmaceuticals, Inc. (PTPI)
Category
Healthcare
EPS for Petros Pharmaceuticals, Inc. (PTPI)
EPS as of June 2026 TTM: $8.51
According to Petros Pharmaceuticals, Inc.'s latest financial reports, its current EPS (TTM) is $8.51. At the end of 2025 the company had an EPS of $-1.56, an increase over its 2024 EPS of $-3.34.
EPS history for Petros Pharmaceuticals, Inc. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $8.51 | -645.51% |
| 2025 | $-1.56 | -53.29% |
| 2024 | $-3.34 | -47.40% |
| 2023 | $-6.35 | -34.40% |
| 2022 | $-9.68 | 17.33% |
| 2021 | $-8.25 | -78.60% |
| 2020 | $-38.55 | -70.83% |
| 2019 | $-132.16 | -59.30% |
| 2018 | $-324.73 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -23.60% |
DE
|
|
| $6.08 | -28.58% |
DE
|
|
| $1.55 | -81.78% |
JP
|
|
| $3.66 | -56.99% |
CH
|
|
| $0.45 | -94.71% |
IL
|
Questions about Petros Pharmaceuticals, Inc.'s earnings per share (EPS)
What is Petros Pharmaceuticals, Inc.'s earnings per share (EPS)?
Petros Pharmaceuticals, Inc.'s earnings per share (EPS) over the last twelve months is $8.51, as of Jun 2026.
What was Petros Pharmaceuticals, Inc.'s earnings per share (EPS) in 2025?
In 2025, Petros Pharmaceuticals, Inc.'s earnings per share (EPS) was $-1.56, compared with $-3.34 in 2024.
How has Petros Pharmaceuticals, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Petros Pharmaceuticals, Inc.'s earnings per share (EPS) was highest in 2025 ($-1.56) and lowest in 2020 ($-38.55).
How does Petros Pharmaceuticals, Inc.'s earnings per share (EPS) compare with similar companies?
Petros Pharmaceuticals, Inc.'s earnings per share (EPS) ($8.51) is higher than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.